NCT06249841View on ClinicalTrials.gov

Feasibility of Cryobiopsy from the Bile Duct - CRYLEO

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

March 4, 2024

Primary Completion Date

August 30, 2024

Study Completion Date

August 30, 2024

Conditions
Neoplasms, Bile Duct
Interventions
DEVICE

1.1mm flexible Cryoprobe SU

Six tissue samples retrieved by standard biopsy forceps and three samples by cryobiopsy (randomized sequence)

Trial Locations (5)

20246

Klinikum Hamburg, Hamburg

45147

Klinikum Essen, Essen

63450

Klinikum Hanau, Hanau

70174

Klinikum Stuttgart, Stuttgart

90419

Klinikum Nürnberg, Nuremberg

Sponsors
All Listed Sponsors
lead

Erbe Elektromedizin GmbH

INDUSTRY

NCT06249841 - Feasibility of Cryobiopsy from the Bile Duct - CRYLEO | Biotech Hunter | Biotech Hunter